Drug Profile
Research programme: ophthalmology therapeutics - Ms Science
Alternative Names: Nucleic acid aptamerLatest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Ms Science
- Class Nucleic acids; Nucleotide aptamers
- Mechanism of Action Protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetic retinopathy
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Diabetic-retinopathy in Japan (Intravitreous, Injection)
- 21 Jan 2016 Early research in Diabetic retinopathy in Japan (Intravitreous) before January 2016